ArriVent BioPharma, Inc. Common Stock (AVBP) Ownership

$18.15

north_east
$1.29 (7.65%)
Day's range
$16.31
Day's range
$18.17

ArriVent BioPharma, Inc. Common Stock Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
HHLR ADVISORS, LTD. 02/14/2025 4.48 M $119.47 M   0.00% 13.35%
ORBIMED ADVISORS LLC 02/14/2025 3.03 M $80.65 M   0.00% 9.01%
SUVRETTA CAPITAL MANAGEMENT, LLC 02/14/2025 2.25 M $59.83 M   21.72% 6.69%
BLACKROCK, INC. 02/07/2025 2.14 M $56.88 M   10.55% 6.36%
FMR LLC 02/13/2025 2.10 M $55.97 M   -0.88% 6.26%
OCTAGON CAPITAL ADVISORS LP 02/14/2025 2.06 M $54.86 M   4.20% 6.13%
SOFINNOVA INVESTMENTS, INC. 02/14/2025 1.70 M $45.20 M   0.00% 5.05%
02/26/2025 1.64 M $43.79 M   100.00% 4.90%
NOVO HOLDINGS A/S 02/14/2025 1.52 M $40.51 M   1.02% 4.53%
GENERAL CATALYST GROUP MANAGEMENT, LLC 01/23/2025 1.49 M $39.82 M   0.00% 4.45%
SC CHINA HOLDING LTD 02/14/2025 663,308 $16.79 M   0.00% 1.98%
GEODE CAPITAL MANAGEMENT, LLC 02/12/2025 596,182 $15.89 M   -0.16% 1.78%
CORMORANT ASSET MANAGEMENT, LP 02/14/2025 585,462 $15.60 M   0.00% 1.74%
NORTHERN TRUST CORP 02/14/2025 241,009 $6.42 M   4.55% 0.72%
HIDDEN LAKE ASSET MANAGEMENT LP 02/14/2025 184,605 $4.92 M   100.00% 0.55%
MORGAN STANLEY 02/14/2025 148,584 $3.96 M   -11.42% 0.44%
WOODLINE PARTNERS LP 02/14/2025 145,797 $3.88 M   20.55% 0.43%
MILLENNIUM MANAGEMENT LLC 02/14/2025 52,545 $1.40 M   -75.74% 0.16%
BANK OF AMERICA CORP /DE/ 02/14/2025 45,544 $1.21 M   5.27% 0.14%
NUVEEN ASSET MANAGEMENT, LLC 02/14/2025 44,282 $1.18 M   0.00% 0.13%
WELLINGTON MANAGEMENT GROUP LLP 02/12/2025 41,921 $1.12 M   100.00% 0.12%
RHUMBLINE ADVISERS 01/30/2025 36,690 $977,412   9.13% 0.11%
CITIGROUP INC 02/12/2025 34,121 $908,983   67.26% 0.10%
ALLIANCEBERNSTEIN L.P. 02/12/2025 28,200 $751,248   0.00% 0.08%
RAFFERTY ASSET MANAGEMENT, LLC 02/14/2025 27,299 $727,245   186.27% 0.08%
ALPS ADVISORS INC 02/13/2025 27,252 $725,993   -0.66% 0.08%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/14/2025 17,114 $456,252   8.41% 0.05%
INTECH INVESTMENT MANAGEMENT LLC 02/11/2025 14,798 $394,219   100.00% 0.04%
COREBRIDGE FINANCIAL, INC. 02/11/2025 14,007 $373,146   -7.02% 0.04%
LEGAL & GENERAL GROUP PLC 02/13/2025 13,627 $363,024   379.15% 0.04%
MANUFACTURERS LIFE INSURANCE COMPANY, THE 02/14/2025 10,018 $266,880   -2.11% 0.03%
UBS ASSET MANAGEMENT AMERICAS INC 02/14/2025 8,165 $217,516   100.00% 0.02%
NEW YORK STATE COMMON RETIREMENT FUND 01/31/2025 7,783 $207,000   34.58% 0.02%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 01/24/2025 7,145 $190,343   100.00% 0.02%
02/11/2025 6,255 $166,633   100.00% 0.02%
02/11/2025 3,100 $82,584   100.00% 0.01%
VIRTUS ETF ADVISERS LLC 02/14/2025 2,747 $73,180   100.00% 0.01%
TOWER RESEARCH CAPITAL LLC (TRC) 02/13/2025 1,599 $42,597   773.77% 0.00%
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. 01/27/2025 1,123 $30,613   100.00% 0.00%
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC 01/17/2025 996 $26,533   12.16% 0.00%
AMALGAMATED BANK 02/04/2025 963 $26,000   0.00% 0.00%
02/19/2025 708 $18,861   100.00% 0.00%
02/13/2025 555 $14,785   1,161.36% 0.00%
STERLING CAPITAL MANAGEMENT LLC 02/13/2025 373 $9,937   532.20% 0.00%
SRS CAPITAL ADVISORS, INC. 02/05/2025 119 $3,171   0.00% 0.00%
DAIWA SECURITIES GROUP INC. 02/07/2025 111 $3,000   100.00% 0.00%
NISA INVESTMENT ADVISORS, LLC 01/17/2025 96 $2,557   255.56% 0.00%
GAMMA INVESTING LLC 01/03/2025 70 $1,865   180.00% 0.00%
ROTHSCHILD INVESTMENT LLC 02/04/2025 45 $1,199   350.00% 0.00%
RONALD BLUE TRUST, INC. 01/22/2025 39 $917   0.00% 0.00%

ArriVent BioPharma, Inc. Common Stock institutional Ownership - FAQ's

During the previous two years, 54 institutional investors and hedge funds held shares of ArriVent BioPharma, Inc. Common Stock. The most heavily invested institutionals were:

Parallel Advisors, LLC: 0

HHLR ADVISORS, LTD.: 4.48 M

ORBIMED ADVISORS LLC: 3.03 M

SUVRETTA CAPITAL MANAGEMENT, LLC: 2.25 M

BlackRock, Inc.: 2.14 M

FMR LLC: 2.1 M

82.31% of ArriVent BioPharma, Inc. Common Stock stock is owned by institutional investors.

Institutional investors have bought a total of 24.95 M shares in the last 24 months. This purchase volume represents approximately $452.87 M in transactions.